OMER
Omeros Corporation
NASDAQ · Healthcare · Biotechnology · US
$18.95
−0.84%Forward multiples
Based on analyst estimates
- P/E forward
- 8.51x
- P/E 2026E
- 21.42x
- P/E 2027E
- 19.06x
- P/E 2028E
- 11.96x
- P/S forward
- 3.45x
Trailing multiples
Trailing twelve months
- P/E TTM
- 9.92x
- PEG TTM
- 0.60x
- Price / book
- -26.71x
- Price / sales
- 35.70x
- Price / cash flow
- -19.98x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 34.45x
- EV / EBITDA
- 9.72x
- EV / EBIT
- -18.18x
- Market cap
- $1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026